Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

First Quarter 2018 Financial Results

Genmab published its First Quarter 2018 financial results and held an investor conference call on May 8. Click here to listen to the webcast replay, click here to download the results, click here to download a podcast of the presentation and click here to download the slide presentation.

strategy_150x110New Strategy Progress Film 

Genmab has launched a new film about the company's strategy and progress.  The film was played for shareholders at the company's Annual General Meeting on April 10.  Click here to watch the film.  


Career Opportunities at Genmab

Genmab is seeking new employees to join our team. Visit our Careers webpages to explore current vacancies, learn about our culture and meet some of our team members